Proethos Fond vs UBS Lux Equity Fund Biotech USD

Proethos Fond vs UBS Lux Equity Fund Biotech USD

1. Proethos Fond

  • Security

    Proethos Fond

  • Fee

    0.65%

  • ISIN

    SE0010547778

  • Holdings

    9

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 10 holdings in Proethos Fond, where the largest holding is Storebrand Grön Obligation A SEK (8.78), followed by Vestas (6.18) and Shimano (5.4). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Proethos Fond and UBS Lux Equity Fund Biotech USD.

Proethos Fond UBS Lux Equity Fund Biotech USD
1. Storebrand Grön Obligation A SEK
Sweden
8.78 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Vestas Wind Systems A/S
Denmark
6.18 %
2. Moderna Inc
9.21 %
3. Shimano ADR
Japan
5.4 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. First Solar Inc
USA
5.08 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Nordex SE
Germany
4.8 %
5. AbbVie Inc
USA
4.91 %
6. Ormat Technologies Inc
USA
4.33 %
6. Gilead Sciences Inc
USA
4.66 %
7. NIBE Industrier B
Sweden
4.32 %
7. Amgen Inc
USA
4.43 %
8. Central Japan Railway Co
Japan
4 %
8. BioNTech SE
4.13 %
9. Enphase Energy Inc
USA
1.51 %
9. Karuna Therapeutics Inc
3.75 %

The list of fund holdings was last updated on July 25, 2025.